[1]
Essrani R, Essrani RK, Mehershahi S, Lohana AK, Sudhakaran A. Oculomotor Nerve Palsy After Influenza Vaccine in Inflammatory Bowel Disease. Cureus. 2018 Dec 21:10(12):e3759. doi: 10.7759/cureus.3759. Epub 2018 Dec 21
[PubMed PMID: 30820379]
[2]
Nishiyama M, Nagase H, Tomioka K, Tanaka T, Yamaguchi H, Ishida Y, Toyoshima D, Fujita K, Maruyama A, Sasaki K, Oyazato Y, Nakagawa T, Takami Y, Nozu K, Nishimura N, Nakashima I, Iijima K. Clinical time course of pediatric acute disseminated encephalomyelitis. Brain & development. 2019 Jun:41(6):531-537. doi: 10.1016/j.braindev.2019.02.011. Epub 2019 Mar 2
[PubMed PMID: 30833092]
[3]
Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, Ghezzi A, Hintzen R, Kornberg A, Pohl D, Rostasy K, Tenembaum S, Wassmer E, International Pediatric Multiple Sclerosis Study Group. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Multiple sclerosis (Houndmills, Basingstoke, England). 2013 Sep:19(10):1261-7. doi: 10.1177/1352458513484547. Epub 2013 Apr 9
[PubMed PMID: 23572237]
[4]
Koelman DL, Mateen FJ. Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome. Journal of neurology. 2015 Sep:262(9):2013-24. doi: 10.1007/s00415-015-7694-7. Epub 2015 Mar 13
[PubMed PMID: 25761377]
[5]
Paolilo RB, Deiva K, Neuteboom R, Rostásy K, Lim M. Acute Disseminated Encephalomyelitis: Current Perspectives. Children (Basel, Switzerland). 2020 Nov 3:7(11):. doi: 10.3390/children7110210. Epub 2020 Nov 3
[PubMed PMID: 33153097]
Level 3 (low-level) evidence
[6]
Alves JM, Marques IB, Gil-Gouveia R. [Vaccination Controversies: An Adult Case of Post-Vaccinal Acute Disseminated Encephalomyelitis]. Acta medica portuguesa. 2019 Feb 1:32(1):81-85. doi: 10.20344/amp.9809. Epub 2019 Feb 1
[PubMed PMID: 30753808]
Level 3 (low-level) evidence
[7]
Rossor T, Benetou C, Wright S, Duignan S, Lascelles K, Robinson R, Das K, Ciccarelli O, Wassmer E, Hemingway C, Lim M, Hacohen Y. Early predictors of epilepsy and subsequent relapse in children with acute disseminated encephalomyelitis. Multiple sclerosis (Houndmills, Basingstoke, England). 2020 Mar:26(3):333-342. doi: 10.1177/1352458518823486. Epub 2019 Feb 7
[PubMed PMID: 30730236]
[8]
Galetta KM, Bhattacharyya S. Multiple Sclerosis and Autoimmune Neurology of the Central Nervous System. The Medical clinics of North America. 2019 Mar:103(2):325-336. doi: 10.1016/j.mcna.2018.10.004. Epub 2018 Dec 3
[PubMed PMID: 30704684]
[9]
Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmunity reviews. 2014 Mar:13(3):215-24
[PubMed PMID: 24514081]
[10]
Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, Belman AL. Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome. Neurology. 2016 Aug 30:87(9 Suppl 2):S38-45. doi: 10.1212/WNL.0000000000002825. Epub
[PubMed PMID: 27572859]
[11]
Absoud M, Lim MJ, Chong WK, De Goede CG, Foster K, Gunny R, Hemingway C, Jardine PE, Kneen R, Likeman M, Nischal KK, Pike MG, Sibtain NA, Whitehouse WP, Cummins C, Wassmer E, UK and Ireland Childhood CNS Inflammatory Demyelination Working Group. Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features. Multiple sclerosis (Houndmills, Basingstoke, England). 2013 Jan:19(1):76-86. doi: 10.1177/1352458512445944. Epub 2012 Apr 19
[PubMed PMID: 22516794]
[12]
Torisu H, Okada K. Vaccination-associated acute disseminated encephalomyelitis. Vaccine. 2019 Feb 14:37(8):1126-1129. doi: 10.1016/j.vaccine.2019.01.021. Epub 2019 Jan 23
[PubMed PMID: 30683508]
[13]
Horellou P, Wang M, Keo V, Chrétien P, Serguera C, Waters P, Deiva K. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis. Journal of neuroimmunology. 2015 Dec 15:289():1-7. doi: 10.1016/j.jneuroim.2015.10.002. Epub 2015 Oct 8
[PubMed PMID: 26616865]
[14]
Brilot F, Dale RC, Selter RC, Grummel V, Kalluri SR, Aslam M, Busch V, Zhou D, Cepok S, Hemmer B. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Annals of neurology. 2009 Dec:66(6):833-42. doi: 10.1002/ana.21916. Epub
[PubMed PMID: 20033986]
[15]
Young NP, Weinshenker BG, Parisi JE, Scheithauer B, Giannini C, Roemer SF, Thomsen KM, Mandrekar JN, Erickson BJ, Lucchinetti CF. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain : a journal of neurology. 2010 Feb:133(Pt 2):333-48. doi: 10.1093/brain/awp321. Epub 2010 Feb 3
[PubMed PMID: 20129932]
[16]
Ketelslegers IA, Visser IE, Neuteboom RF, Boon M, Catsman-Berrevoets CE, Hintzen RQ. Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children. Multiple sclerosis (Houndmills, Basingstoke, England). 2011 Apr:17(4):441-8. doi: 10.1177/1352458510390068. Epub 2010 Dec 8
[PubMed PMID: 21148017]
[17]
Li K, Li M, Wen L, Wang Q, Ding X, Wang J. Clinical Presentation and Outcomes of Acute Disseminated Encephalomyelitis in Adults Worldwide: Systematic Review and Meta-Analysis. Frontiers in immunology. 2022:13():870867. doi: 10.3389/fimmu.2022.870867. Epub 2022 Jun 9
[PubMed PMID: 35757742]
Level 1 (high-level) evidence
[18]
Kawanaka Y, Ando K, Ishikura R, Katsuura T, Wakata Y, Kodama H, Takaki H, Takada Y, Ono J, Yamakado K. Delayed appearance of transient hyperintensity foci on T1-weighted magnetic resonance imaging in acute disseminated encephalomyelitis. Japanese journal of radiology. 2019 Apr:37(4):277-282. doi: 10.1007/s11604-018-00808-w. Epub 2019 Jan 22
[PubMed PMID: 30671706]
[19]
Anand KS, Agrawal AK, Garg J, Dhamija RK, Mahajan RK. Spectrum of neurological complications in chikungunya fever: experience at a tertiary care centre and review of literature. Tropical doctor. 2019 Apr:49(2):79-84. doi: 10.1177/0049475518825219. Epub 2019 Jan 24
[PubMed PMID: 30678544]
[20]
Codjia P, Ayrignac X, Carra-Dalliere C, Cohen M, Charif M, Lippi A, Collongues N, Corti L, De Seze J, Lebrun C, Vukusic S, Durand-Dubief F, Labauge P, SFSEP and OFSEP. Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases. Multiple sclerosis and related disorders. 2019 Feb:28():109-116. doi: 10.1016/j.msard.2018.12.022. Epub 2018 Dec 18
[PubMed PMID: 30592992]
Level 2 (mid-level) evidence
[21]
Ketelslegers IA, Neuteboom RF, Boon M, Catsman-Berrevoets CE, Hintzen RQ, Dutch Pediatric MS Study Group. A comparison of MRI criteria for diagnosing pediatric ADEM and MS. Neurology. 2010 May 4:74(18):1412-5. doi: 10.1212/WNL.0b013e3181dc138b. Epub 2010 Mar 24
[PubMed PMID: 20335562]
[22]
Armangue T, Olivé-Cirera G, Martínez-Hernandez E, Sepulveda M, Ruiz-Garcia R, Muñoz-Batista M, Ariño H, González-Álvarez V, Felipe-Rucián A, Jesús Martínez-González M, Cantarín-Extremera V, Concepción Miranda-Herrero M, Monge-Galindo L, Tomás-Vila M, Miravet E, Málaga I, Arrambide G, Auger C, Tintoré M, Montalban X, Vanderver A, Graus F, Saiz A, Dalmau J, Spanish Pediatric anti-MOG Study Group. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. The Lancet. Neurology. 2020 Mar:19(3):234-246. doi: 10.1016/S1474-4422(19)30488-0. Epub 2020 Feb 10
[PubMed PMID: 32057303]
Level 2 (mid-level) evidence
[23]
Huda S, Whittam D, Bhojak M, Chamberlain J, Noonan C, Jacob A. Neuromyelitis optica spectrum disorders. Clinical medicine (London, England). 2019 Mar:19(2):169-176. doi: 10.7861/clinmedicine.19-2-169. Epub
[PubMed PMID: 30872305]
[24]
Cole J, Evans E, Mwangi M, Mar S. Acute Disseminated Encephalomyelitis in Children: An Updated Review Based on Current Diagnostic Criteria. Pediatric neurology. 2019 Nov:100():26-34. doi: 10.1016/j.pediatrneurol.2019.06.017. Epub 2019 Jul 3
[PubMed PMID: 31371120]
[25]
Pohl D, Tenembaum S. Treatment of acute disseminated encephalomyelitis. Current treatment options in neurology. 2012 Jun:14(3):264-75. doi: 10.1007/s11940-012-0170-0. Epub
[PubMed PMID: 22476745]
[26]
Bhatt P, Bray L, Raju S, Dapaah-Siakwan F, Patel A, Chaudhari R, Donda K, Bhatt NS, Dave M, Linga VG, Lekshminarayanan A, Patel SV, Billimoria ZC, Zuckerman S, Yagnik P, Singh D. Temporal Trends of Pediatric Hospitalizations with Acute Disseminated Encephalomyelitis in the United States: An Analysis from 2006 to 2014 using National Inpatient Sample. The Journal of pediatrics. 2019 Mar:206():26-32.e1. doi: 10.1016/j.jpeds.2018.10.044. Epub 2018 Dec 6
[PubMed PMID: 30528761]
[27]
Yae Y, Kawano G, Yokochi T, Imagi T, Akita Y, Ohbu K, Matsuishi T. Fulminant acute disseminated encephalomyelitis in children. Brain & development. 2019 Apr:41(4):373-377. doi: 10.1016/j.braindev.2018.11.007. Epub 2018 Dec 3
[PubMed PMID: 30522797]
[28]
Ketelslegers IA, Van Pelt DE, Bryde S, Neuteboom RF, Catsman-Berrevoets CE, Hamann D, Hintzen RQ. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort. Multiple sclerosis (Houndmills, Basingstoke, England). 2015 Oct:21(12):1513-20. doi: 10.1177/1352458514566666. Epub 2015 Feb 6
[PubMed PMID: 25662345]
[29]
Absoud M, Parslow RC, Wassmer E, Hemingway C, Duncan HP, Cummins C, Lim MJ, UK & Ireland Childhood CNS Inflammatory Demyelination Working Group and the the Paediatric Intensive Care Audit Network. Severe acute disseminated encephalomyelitis: a paediatric intensive care population-based study. Multiple sclerosis (Houndmills, Basingstoke, England). 2011 Oct:17(10):1258-61. doi: 10.1177/1352458510382554. Epub 2010 Sep 27
[PubMed PMID: 20876155]
[30]
Deiva K, Cobo-Calvo A, Maurey H, De Chalus A, Yazbeck E, Husson B, Vukusic S, Serguerra C, Horellou P, Marignier R, Kidbiosep Cohort. Risk factors for academic difficulties in children with myelin oligodendrocyte glycoprotein antibody-associated acute demyelinating syndromes. Developmental medicine and child neurology. 2020 Sep:62(9):1075-1081. doi: 10.1111/dmcn.14594. Epub 2020 Jun 22
[PubMed PMID: 32567093]
[31]
Javed A, Khan O. Acute disseminated encephalomyelitis. Handbook of clinical neurology. 2014:123():705-17. doi: 10.1016/B978-0-444-53488-0.00035-3. Epub
[PubMed PMID: 25015513]
[32]
VAN BOGAERT L. Post-infectious encephalomyelitis and multiple sclerosis; the significance of perivenous encephalomyelitis. Journal of neuropathology and experimental neurology. 1950 Jul:9(3):219-49
[PubMed PMID: 15437201]
[33]
Mader I, Wolff M, Niemann G, Küker W. Acute haemorrhagic encephalomyelitis (AHEM): MRI findings. Neuropediatrics. 2004 Apr:35(2):143-6
[PubMed PMID: 15127316]
[34]
Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC, White OB, Broadley S, Lechner-Scott J, Vucic S, Henderson APD, Barnett MH, Reddel SW, Brilot F, Dale RC, Australasian and New Zealand MOG Study Group. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. Journal of neurology, neurosurgery, and psychiatry. 2018 Feb:89(2):127-137. doi: 10.1136/jnnp-2017-316880. Epub 2017 Nov 15
[PubMed PMID: 29142145]